High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study (Q44585429)

From Wikidata
Jump to navigation Jump to search
scientific article published on 15 September 2003
edit
Language Label Description Also known as
English
High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study
scientific article published on 15 September 2003

    Statements

    High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study (English)
    Gregory G Schwartz
    William J Sasiela
    Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering Study Investigators

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit